Join us on Wednesday, 27 May 2026 at 9am EDT (New York) | 2pm BST (London) | 3pm CEST (Paris) to explore the critical factors an organization must consider when implementing AI-enabled automation.
In this webinar, the presenters will guide attendees through a practical roadmap for implementing intelligent automation into the pharma microbiology workflow. From initial planning to commercial use, this session lays the foundation for an organization to maximize value while maintaining compliance and control during the implementation process.
Overview
In pharma microbiology, processes often span multiple functions, including QC and production, requiring alignment across diverse stakeholders such as IT, quality assurance, and operations teams. Securing early understanding, engagement, and cross-functional support is critical to successful implementation.
This session will provide a pathway to technology adoption that supports the goals of bringing AI-powered automation into the pharma QC workflow, including:
- Reducing human error
- Enhancing traceability
- Upholding data integrity
- Increasing throughput
Our subject matter experts will give you critical, in-depth insight into each of the phases of implementation:
- Pre-implementation and planning
- System implementation
- Validation and Maintaining the Validated State
They will address the practical challenges that can arise during each phase as well as the factors that must be considered to ensure a smooth operational transition.
The webinar will conclude with a 20 minute roundtable Q&A with the presenters.
Presenters:
Dr Steven Giglio, PhD, Chief Scientific Officer, Clever Culture Systems
Bianca De Young, Microbiology Services Manager, Clever Culture Systems
Dr Chris Ramsey, PhD, Business Development Director, North America, Clever Culture Systems
Take the first step in setting up your program for success, register here.
